Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-16 Purchase |
2024-09-17 8:28 pm |
MBX Biosciences Inc. | MBX | Mathers Edward T Director 10% Owner |
500,000 | $16 | $8,000,000 | 3,614,486 (Indirect) |
View |
| 2024-04-22 Purchase |
2024-04-24 5:00 pm |
Korro Bio Inc. | KRRO | Mathers Edward T 10% Owner |
17,857 | $56 | $999,992 | 1,090,793 (Indirect) |
View |
| 2023-07-17 Purchase |
2023-07-19 7:10 pm |
Savara Inc | SVRA | Mathers Edward T 10% Owner |
333,333 | $3 | $999,999 | 24,471,264 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-31 Option Award |
2025-04-02 4:48 pm |
N/A N/A |
OnKure Therapeutics Inc. | OKUR | Mathers Edward T Director |
2,580 | $0 | 2,580 (Direct) |
View |
| 2025-03-07 Option Award |
2025-03-11 4:28 pm |
N/A 2035-03-06 |
Senti Biosciences Inc. | SNTI | Mathers Edward T Director |
43,900 | $0 | 43,900 (Direct) |
View |
| 2024-10-04 Option Award |
2024-10-08 7:27 pm |
N/A 2034-10-03 |
OnKure Therapeutics Inc. | OKUR | Mathers Edward T Director |
15,300 | $0 | 15,300 (Direct) |
View |
| 2024-09-16 Conversion |
2024-09-17 8:28 pm |
N/A N/A |
MBX Biosciences Inc. | MBX | Mathers Edward T Director 10% Owner |
40,557,180 | $0 | 3,614,486 (Indirect) |
View |
| 2024-09-12 Option Award |
2024-09-13 5:11 pm |
N/A 2034-09-11 |
MBX Biosciences Inc. | MBX | Mathers Edward T Director 10% Owner |
15,963 | $0 | 15,963 (Direct) |
View |
Ownership |
2024-09-12 7:31 pm |
N/A N/A |
MBX Biosciences Inc. | MBX | Mathers Edward T Director 10% Owner |
0 | $0 | 3,114,486 (Indirect) |
View |
| 2024-07-10 Option Award |
2024-07-12 4:30 pm |
N/A 2034-07-09 |
Senti Biosciences Inc. | SNTI | Mathers Edward T Director |
62,500 | $0 | 62,500 (Direct) |
View |
| 2024-06-21 Exercise |
2024-06-25 4:38 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS INC. | RYTM | Mathers Edward T Director |
3,000 | $0 | 8,771 (Direct) |
View |
| 2024-06-18 Option Award |
2024-06-20 9:43 pm |
N/A 2034-06-17 |
RHYTHM PHARMACEUTICALS INC. | RYTM | Mathers Edward T Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2024-06-18 Option Award |
2024-06-20 4:30 pm |
N/A 2034-06-17 |
Inozyme Pharma Inc. | INZY | Mathers Edward T Director |
28,000 | $0 | 28,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 4:40 pm |
N/A 2034-06-12 |
Trevi Therapeutics Inc. | TRVI | Mathers Edward T Director |
30,000 | $0 | 30,000 (Direct) |
View |
Ownership |
2023-11-07 9:31 pm |
N/A N/A |
Korro Bio Inc. | KRRO | Mathers Edward T 10% Owner |
0 | $0 | 1,072,936 (Indirect) |
View |
| 2023-06-28 Option Award |
2023-06-30 4:14 pm |
N/A 2033-06-27 |
Trevi Therapeutics Inc. | TRVI | Mathers Edward T Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 3:46 pm |
N/A 2033-06-22 |
SYNLOGIC INC. | SYBX | Mathers Edward T Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 4:58 pm |
N/A 2033-06-20 |
RHYTHM PHARMACEUTICALS INC. | RYTM | Mathers Edward T Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 7:24 pm |
N/A 2033-06-15 |
Senti Biosciences Inc. | SNTI | Mathers Edward T Director |
62,500 | $0 | 62,500 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 4:16 pm |
N/A 2033-06-12 |
Inozyme Pharma Inc. | INZY | Mathers Edward T Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 8:09 pm |
N/A 2033-06-05 |
Reneo Pharmaceuticals Inc. | RPHM | Mathers Edward T Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2023-03-02 Other |
2023-03-06 1:47 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS INC. | RYTM | Mathers Edward T Director |
5,771 | $0 | 11,542 (Indirect) |
View |
Ownership |
2023-01-03 4:33 pm |
N/A 2027-01-24 |
ObsEva SA | OBSV | Mathers Edward T Director |
0 | $0 | 158,780 (Direct) |
View |
| 2022-07-13 Option Award |
2022-07-15 6:09 pm |
N/A 2032-07-12 |
Senti Biosciences Inc. | SNTI | Mathers Edward T Director |
125,000 | $0 | 125,000 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-27 5:08 pm |
N/A 2032-06-22 |
Akouos Inc. | AKUS | Mathers Edward T Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-23 5:04 pm |
N/A 2032-06-22 |
Trevi Therapeutics Inc. | TRVI | Mathers Edward T Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 4:32 pm |
N/A 2032-06-09 |
Inozyme Pharma Inc. | INZY | Mathers Edward T Director |
9,367 | $0 | 9,367 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 4:45 pm |
N/A 2032-06-09 |
SYNLOGIC INC. | SYBX | Mathers Edward T Director |
27,000 | $0 | 27,000 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 4:35 pm |
N/A 2032-06-07 |
RHYTHM PHARMACEUTICALS INC. | RYTM | Mathers Edward T Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 6:23 pm |
N/A 2032-06-01 |
Mirum Pharmaceuticals Inc. | MIRM | Mathers Edward T Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-03 5:26 pm |
N/A 2032-05-31 |
Reneo Pharmaceuticals Inc. | RPHM | Mathers Edward T Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2022-04-11 Option Award |
2022-04-13 5:32 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Mathers Edward T Director |
3,000,000 | $1.899 | 3,948,948 (Indirect) |
View |
| 2022-04-11 Option Award |
2022-04-13 5:32 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Mathers Edward T Director |
948,948 | $1.9 | 3,948,948 (Indirect) |
View |